Negative Impact of Gemtuzumab Ozogamicin on CD33-Positive Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report

Negative Impact of Gemtuzumab Ozogamicin on CD33-Positive Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report

Introduction: Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a rare subtype of T-cell leukemia that phenotypically expresses mature T-cell markers and immature myeloid markers such as CD33. Gemtuzumab ozogamicin (GO) is a novel agent for the CD33 molecular targeting antibody conjug...

Full description

Bibliographic Details
Main Authors: Osamu Imataki, Haruyuki Fujita, Makiko Uemura
Format: Article
Language:English
Published: Karger Publishers 2024-02-01
Series:Case Reports in Oncology
Subjects:
early t-cell precursor acute lymphoblastic leukemia
gemtuzumab ozogamicin
cd33
antibody-drug conjugate
Online Access:https://beta.karger.com/Article/FullText/536424

Similar Items

Similar Items